Literature DB >> 32133108

Type of sedation and the need for unplanned interventions during ERCP: analysis of the clinical outcomes research initiative national endoscopic database (CORI-NED).

Zachary L Smith1,2, Katelin B Nickel3, Margaret A Olsen3, John J Vargo4, Vladimir M Kushnir2.   

Abstract

BACKGROUND AND AIMS: Recent studies suggest that sedation provided by anaesthesia professionals may be less protective against serious adverse events than previously believed, however, data are lacking regarding endoscopic retrograde cholangiopancreatography (ERCP). Using the clinical outcomes research initiative national endoscopic database (CORI-NED), we aimed to assess whether mode of sedation was associated with rates of unplanned interventions (UIs) during ERCP. PATIENTS AND METHODS: All subjects from CORI-NED undergoing ERCP from 2004 to 2014 were identified and stratified into three groups based on the initial mode of anaesthesia: endoscopist-directed sedation (EDS), monitored anaesthesia care without an endotracheal tube (MAC-WET) and general endotracheal anaesthesia (GEA). The primary outcome was UIs. To assess the impact of sedation mode on UIs, multivariable logistic regression models were created adjusting for demographic, physician and procedure-level variables.
DESIGN: Population-based study.
RESULTS: 26 698 ERCPs were analysed (7588 EDS, 8395 MAC-WET, 10 715 GEA). UIs occurred in 320 ERCPs (1.2%). EDS was associated with a higher risk of UIs compared with sedation administered by an anaesthesia professional (OR 1.86, 95% CI 1.44 to 2.42). Additional factors associated with a higher risk of UIs included ASA class IV compared with class II (OR 3.18, 95% CI 2.00 to 5.06) and ERCPs done in community (OR 1.41, 1.04 to 1.91) and health maintenance organisations (OR 3.75, 2.01 to 6.99) hospitals.
CONCLUSION: EDS is associated with a higher risk of UIs during ERCP compared with sedation administered by an anaesthesia professional. Higher ASA class and procedures performed in non-university hospitals were also associated with a higher risk of UIs. This study suggests that, when available, sedation using an anaesthesia professional should be utilised for ERCP. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adverse events; anesthesia; endoscopic retrograde pancreatography; endoscopy; sedation

Year:  2019        PMID: 32133108      PMCID: PMC7043086          DOI: 10.1136/flgastro-2019-101175

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  18 in total

Review 1.  Anaesthesia in the prone position.

Authors:  H Edgcombe; K Carter; S Yarrow
Journal:  Br J Anaesth       Date:  2008-02       Impact factor: 9.166

2.  Patient safety during sedation by anesthesia professionals during routine upper endoscopy and colonoscopy: an analysis of 1.38 million procedures.

Authors:  John J Vargo; Paul J Niklewski; J Lucas Williams; James F Martin; Douglas O Faigel
Journal:  Gastrointest Endosc       Date:  2016-02-18       Impact factor: 9.427

3.  Is the American Society of Anesthesiologists classification useful in risk stratification for endoscopic procedures?

Authors:  Brintha K Enestvedt; Glenn M Eisen; Jennifer Holub; David A Lieberman
Journal:  Gastrointest Endosc       Date:  2013-03       Impact factor: 9.427

4.  A prospective assessment of sedation-related adverse events and patient and endoscopist satisfaction in ERCP with anesthesiologist-administered sedation.

Authors:  Tyler M Berzin; Sirish Sanaka; Sheila R Barnett; Eswar Sundar; Paul S Sepe; Moshe Jakubowski; Douglas K Pleskow; Ram Chuttani; Mandeep S Sawhney
Journal:  Gastrointest Endosc       Date:  2011-02-12       Impact factor: 9.427

5.  Sedation with propofol for routine ERCP in high-risk octogenarians: a randomized, controlled study.

Authors:  Andrea Riphaus; Nikos Stergiou; Till Wehrmann
Journal:  Am J Gastroenterol       Date:  2005-09       Impact factor: 10.864

6.  Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial.

Authors:  John J Vargo; Gregory Zuccaro; John A Dumot; Kenneth M Shermock; J Brad Morrow; Darwin L Conwell; Patricia A Trolli; Walter G Maurer
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

7.  Impact of Endotracheal Intubation on Interventional Endoscopy Unit Efficiency Metrics at a Tertiary Academic Medical Center.

Authors:  Yaseen B Perbtani; Robert J Summerlee; Dennis Yang; Qi An; Alejandro Suarez; J Blair Williamson; Charles W Shrode; Anand R Gupte; Shailendra S Chauhan; Peter V Draganov; Chris E Forsmark; Myron Chang; Mihir S Wagh
Journal:  Am J Gastroenterol       Date:  2016-03-29       Impact factor: 10.864

8.  Sedation with propofol for interventional endoscopy by trained nurses in high-risk octogenarians: a prospective, randomized, controlled study.

Authors:  D Schilling; A Rosenbaum; S Schweizer; H Richter; B Rumstadt
Journal:  Endoscopy       Date:  2009-04-01       Impact factor: 10.093

9.  Propofol infusion versus intermittent meperidine and midazolam injection for conscious sedation in ERCP.

Authors:  Pradermchai Kongkam; Rungsun Rerknimitr; Sahadol Punyathavorn; Chitr Sitthi-Amorn; Yuwadee Ponauthai; Narongrit Prempracha; Pinit Kullavanijaya
Journal:  J Gastrointestin Liver Dis       Date:  2008-09       Impact factor: 2.008

10.  Experience of propofol sedation in a UK ERCP practice: lessons for service provision.

Authors:  D Joshi; B Paranandi; G El Sayed; J Down; G J Johnson; M H Chapman; S P Pereira; G J M Webster
Journal:  Frontline Gastroenterol       Date:  2014-09-10
View more
  2 in total

1.  Anaesthesia and sedation for endoscopic retrograde cholangiopancreatography.

Authors:  A M Henriksson; S V Thakrar
Journal:  BJA Educ       Date:  2022-07-19

2.  Controversies in ERCP: Indications and preparation.

Authors:  Christoph F Dietrich; Noor L Bekkali; Sean Burmeister; Yi Dong; Simon M Everett; Michael Hocke; Andre Ignee; Wei On; Srisha Hebbar; Kofi Oppong; Siyu Sun; Christian Jenssen; Barbara Braden
Journal:  Endosc Ultrasound       Date:  2022 May-Jun       Impact factor: 5.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.